Study suggests a new way to personalize anti-CTLA-4 therapy for cancers

[News]

A Ludwig Cancer Research study has identified a novel mechanism by which a type of cancer immunotherapy known as CTLA-4 blockade can disable suppressive immune cells to aid the destruction of certain tumors.

More... (https://www.news-medical.net/news/20210215/Study-suggests-a-new-way-to-personalize-anti-CTLA-4-therapy-for-cancers.aspx)